AVEO Pharmaceuticals, Inc. AVEO
15.00 +15.00
Day range unavailable
52-week range unavailable
AVEO revenue history
Revenue is income from the company’s ordinary business activities.
42,295,000 USD
FY 2021 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | 42,295,000 | 36,276,000 | 602.69% |
| FY 2020 | 2020-12-31 | 6,019,000 | -22,776,000 | -79.10% |
| FY 2019 | 2019-12-31 | 28,795,000 | 23,386,000 | 432.35% |
| FY 2018 | 2018-12-31 | 5,409,000 | -2,170,000 | -28.63% |
| FY 2017 | 2017-12-31 | 7,579,000 | 5,064,000 | 201.35% |
| FY 2016 | 2016-12-31 | 2,515,000 | -16,509,000 | -86.78% |
| FY 2015 | 2015-12-31 | 19,024,000 | 901,000 | 4.97% |
| FY 2014 | 2014-12-31 | 18,123,000 | 16,830,000 | 1301.62% |
| FY 2013 | 2013-12-31 | 1,293,000 | -17,993,000 | -93.30% |
| FY 2012 | 2012-12-31 | 19,286,000 | -145,563,000 | -88.30% |
| FY 2011 | 2011-12-31 | 164,849,000 | 120,167,000 | 268.94% |
| FY 2010 | 2010-12-31 | 44,682,000 | 23,963,000 | 115.66% |
| FY 2009 | 2009-12-31 | 20,719,000 | 1,059,000 | 5.39% |
| FY 2008 | 2008-12-31 | 19,660,000 | 8,625,862 | 78.17% |
| FY 2007 | 2007-12-31 | 11,034,138 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:59.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.